NCT05800795

Brief Summary

The attachment of peri implant soft tissue to the implant serves as a biological seal that can prevent the development of inflammatory peri-implant diseases. Presence of contaminants has been suggested to be associated with tissue damaging inflammation and titanium wear microparticles were demonstrated to activate osteoclastic action. Er: YAG laser has been extensively investigated clinically for applications for treating periimplantitis either independently or in combination with other techniques, showing favorable outcomes. Plasma spray treatment can decontaminate surfaces without modifying their topography. It is also able to increase the surface energy by obtaining more hydrophilic surfaces, which may increase the capacity of the titanium oxide layer to interact with cells and proteins of surrounding tissue improving cell adhesion to the treated surface.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 20, 2021

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 13, 2022

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 22, 2022

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

March 5, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

April 6, 2023

Completed
Last Updated

April 6, 2023

Status Verified

April 1, 2023

Enrollment Period

12 months

First QC Date

March 5, 2023

Last Update Submit

April 4, 2023

Conditions

Keywords

healing abutmentplasma sprayEr: YAG laser

Outcome Measures

Primary Outcomes (2)

  • histological assessment measuring inflammatory cells count.

    sections of biopsies from peri-implant soft tissue stained with hematoxylin and eosin stain. H\&E stain was used for measuring inflammatory cells count and Masson's Trichrome stains for measuring collagen fibers area fraction.

    two weeks after stage two surgery

  • histological assessment measuring collagen fibers area fraction.

    sections of biopsies from peri-implant soft tissue stained with Masson trichrome stain.

    two weeks after stage two surgery

Secondary Outcomes (3)

  • scanning electron microscopic analysis

    two weeks after stage two surgery

  • clinical assessment measuring plaque index

    two weeks after stage two surgery and after three months

  • clinical assessment measuring gingival index

    two weeks after stage two surgery and after three months

Study Arms (3)

laser group

ACTIVE COMPARATOR

Healing abutments have been treated by Er:YAG laser. The laser-machine (with a wavelength of 2.940 nm) was used with settings of 100 mJ/pulse (12.7 J/cm₂) and 10 Hz. The healing abutments' surface was thoroughly decontaminated by the fiber tip in a semicircular contact mode with copious water irrigation.

Device: Er: YAG laser

plasma group

ACTIVE COMPARATOR

Healing abutments have been sprayed with an atmospheric pressure plasma device (Piezobrush® PZ2) , by using active gas, low-temperature plasma treatment under irradiation at 0.2 MPa for a total of 80 seconds at 10 mm (20 seconds per each surface)

Device: plasma spray

control group

NO INTERVENTION

Healing abutments were installed as they came from industry and received no further treatment.

Interventions

surface treatment with Er: YAG laser for heating abutments

laser group

surface treatment with plasma spray for heating abutments

plasma group

Eligibility Criteria

Age20 Years - 45 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Male and female patients with age range from 20 to 45 years old.
  • Patients need placement of fixed implant-supported prosthesis in maxillary arch.
  • Patients who are medically free from any systemic diseases as evidenced by the health questionnaire, using modified Cornell medical index (Pendleton et al., 2004).
  • patients with good oral hygiene (Plaque Index and bleeding on probing less than or equal to grade 1).
  • Absence of any local conditions affecting bone-implant osseointegration (e.g., infection and poor bone density).
  • The presence of sufficient bone width and height that permit the placement of implant with minimum diameter 3.5 mm and 8.5 mm length.

You may not qualify if:

  • Presence of acute infections.
  • Smokers.
  • Pregnancy and lactation.
  • Patients with a history of bisphosphonates therapy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ain Shams University -Faculty of dentistry

Cairo, 1156, Egypt

Location

MeSH Terms

Interventions

Lasers, Solid-State

Intervention Hierarchy (Ancestors)

LasersOptical DevicesEquipment and SuppliesRadiation Equipment and Supplies

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
assessor of clinical parameters, histological samples and scanning electron microscopy samples
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: comparison between three groups
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant lecturer of oral medicine and periodontology

Study Record Dates

First Submitted

March 5, 2023

First Posted

April 6, 2023

Study Start

June 20, 2021

Primary Completion

June 13, 2022

Study Completion

September 22, 2022

Last Updated

April 6, 2023

Record last verified: 2023-04

Data Sharing

IPD Sharing
Will not share

Locations